Novel approaches to understanding precursor protease autoprocessing in intact viruses

NIH RePORTER · NIH · R01 · $516,213 · view on reporter.nih.gov ↗

Abstract

Project Abstract This project aims to use two highly novel and powerful assays to investigate HIV-1 protease (PR) precursor dimerization and autoprocessing in the context of intact viruses. In contrast to studies of the mature PR, little is known about how the precursor PR is activated and regulated, particularly under physiological conditions. We have developed a flow virometry-based assay that enables high-throughput analysis and sorting of individual viral particles and provides a rapid and efficient method for identifying determinants of precursor PR activation. To complement this method, we have also developed a selective reaction monitoring-mass spectrometry (SRM-MS) assay that allows simultaneous monitoring of all Gag and Gag-Pol cleavage sites with extremely accurate quantification of cleavage site processing efficiency. We will use these assays to: Aim 1: Identify determinants of precursor PR autoprocessing in the context of intact viruses. Aim 2: Determine the timing of PR activation in relation to budding, and define how premature activation of precursor PR activity is regulated. Aim 3: Evaluate how drug resistance and accessory mutations affect processing, budding, and the infectivity of viruses under physiological conditions.

Key facts

NIH application ID
9901451
Project number
5R01AI140847-02
Recipient
CASE WESTERN RESERVE UNIVERSITY
Principal Investigator
John Christian Tilton
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$516,213
Award type
5
Project period
2019-04-01 → 2024-03-31